Long-Acting Injectable Antipsychotic Treatment in Schizophrenia and Co-occurring Substance Use Disorders: A Systematic Review
Objectives: Co-occurring substance use disorders (SUDs) among individuals with schizophrenia are a prevalent and complex psychiatric comorbidity, which is associated with increased symptom severity, worsened illness trajectory and high rates of treatment non-adherence. Recent evidence suggests that...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2021-12-01
|
| Series: | Frontiers in Psychiatry |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fpsyt.2021.808002/full |
| _version_ | 1819176266037723136 |
|---|---|
| author | Alexandria S. Coles Dunja Knezevic Tony P. George Tony P. George Christoph U. Correll Christoph U. Correll Christoph U. Correll John M. Kane John M. Kane David Castle David Castle |
| author_facet | Alexandria S. Coles Dunja Knezevic Tony P. George Tony P. George Christoph U. Correll Christoph U. Correll Christoph U. Correll John M. Kane John M. Kane David Castle David Castle |
| author_sort | Alexandria S. Coles |
| collection | DOAJ |
| description | Objectives: Co-occurring substance use disorders (SUDs) among individuals with schizophrenia are a prevalent and complex psychiatric comorbidity, which is associated with increased symptom severity, worsened illness trajectory and high rates of treatment non-adherence. Recent evidence suggests that the use of long-acting injectable (LAI) antipsychotics may provide an effective treatment option for individuals with this dual-diagnosis.Methods: A systematic review of the literature was conducted using the databases PubMed, PsychInfo and Google Scholar for English-language studies, investigating the use of LAIs in co-occurring schizophrenia and substance use disorders (SCZ-SUDs).Results: Eight reports [one case study (n = 1), one case series (n = 8), three open-label retrospective studies (n = 75), and three randomized controlled trials (n = 273)] investigated the use of LAI antipsychotics in 357 participants with SCZ-SUDs [alcohol use disorder: 5 studies, n = 282; cocaine use disorder: 5 studies, n = 85; amphetamine use disorder: 1 study, n = 1; cannabis use disorder: 3 studies, n = 160; opioid use disorder: 3 studies, n = 19; methylenedioxymethamphetamine (MDMA) use disorder: 2 studies, n = 9; ketamine use disorder: 1 study, n = 4] and were included in this systematic review. Findings indicate significant improvements in substance use related outcomes across 7 of 8 studies, while in 6 of 8 studies, significant improvements in psychopathology-related outcomes were reported.Conclusions: LAI antipsychotics may be an efficacious intervention option for the treatment of SCZ-SUDs. However, varying methodological rigor, generally small sample sizes and heterogeneity of samples, settings, substances of abuse, tested LAIs and comparators, as well as psychosocial cotreatments and level of reported detail across studies requires that these findings be considered preliminary and interpreted with caution. Further research is required to better understand the effects of LAIs among individuals with SCZ-SUDs. |
| first_indexed | 2024-12-22T21:08:01Z |
| format | Article |
| id | doaj.art-d838a8e5c04a49caa13be162c7108a80 |
| institution | Directory Open Access Journal |
| issn | 1664-0640 |
| language | English |
| last_indexed | 2024-12-22T21:08:01Z |
| publishDate | 2021-12-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Psychiatry |
| spelling | doaj.art-d838a8e5c04a49caa13be162c7108a802022-12-21T18:12:37ZengFrontiers Media S.A.Frontiers in Psychiatry1664-06402021-12-011210.3389/fpsyt.2021.808002808002Long-Acting Injectable Antipsychotic Treatment in Schizophrenia and Co-occurring Substance Use Disorders: A Systematic ReviewAlexandria S. Coles0Dunja Knezevic1Tony P. George2Tony P. George3Christoph U. Correll4Christoph U. Correll5Christoph U. Correll6John M. Kane7John M. Kane8David Castle9David Castle10Centre for Complex Interventions, Centre for Addictions and Mental Health, Toronto, ON, CanadaCentre for Complex Interventions, Centre for Addictions and Mental Health, Toronto, ON, CanadaCentre for Complex Interventions, Centre for Addictions and Mental Health, Toronto, ON, CanadaDepartment of Psychiatry, University of Toronto, Toronto, ON, CanadaDepartment of Psychiatry and Molecular Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, United StatesDepartment of Child and Adolescent Psychiatry, Charité Universitätsmedizin Berlin, Berlin, GermanyDepartment of Psychiatry, The Zucker Hillside Hospital, Glen Oaks, NY, United StatesDepartment of Psychiatry and Molecular Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, United StatesDepartment of Psychiatry, The Zucker Hillside Hospital, Glen Oaks, NY, United StatesCentre for Complex Interventions, Centre for Addictions and Mental Health, Toronto, ON, CanadaDepartment of Psychiatry, University of Toronto, Toronto, ON, CanadaObjectives: Co-occurring substance use disorders (SUDs) among individuals with schizophrenia are a prevalent and complex psychiatric comorbidity, which is associated with increased symptom severity, worsened illness trajectory and high rates of treatment non-adherence. Recent evidence suggests that the use of long-acting injectable (LAI) antipsychotics may provide an effective treatment option for individuals with this dual-diagnosis.Methods: A systematic review of the literature was conducted using the databases PubMed, PsychInfo and Google Scholar for English-language studies, investigating the use of LAIs in co-occurring schizophrenia and substance use disorders (SCZ-SUDs).Results: Eight reports [one case study (n = 1), one case series (n = 8), three open-label retrospective studies (n = 75), and three randomized controlled trials (n = 273)] investigated the use of LAI antipsychotics in 357 participants with SCZ-SUDs [alcohol use disorder: 5 studies, n = 282; cocaine use disorder: 5 studies, n = 85; amphetamine use disorder: 1 study, n = 1; cannabis use disorder: 3 studies, n = 160; opioid use disorder: 3 studies, n = 19; methylenedioxymethamphetamine (MDMA) use disorder: 2 studies, n = 9; ketamine use disorder: 1 study, n = 4] and were included in this systematic review. Findings indicate significant improvements in substance use related outcomes across 7 of 8 studies, while in 6 of 8 studies, significant improvements in psychopathology-related outcomes were reported.Conclusions: LAI antipsychotics may be an efficacious intervention option for the treatment of SCZ-SUDs. However, varying methodological rigor, generally small sample sizes and heterogeneity of samples, settings, substances of abuse, tested LAIs and comparators, as well as psychosocial cotreatments and level of reported detail across studies requires that these findings be considered preliminary and interpreted with caution. Further research is required to better understand the effects of LAIs among individuals with SCZ-SUDs.https://www.frontiersin.org/articles/10.3389/fpsyt.2021.808002/fullschizophreniasubstance use disorder (SUD)long acting injectable (LAI)antipsychotictreatment |
| spellingShingle | Alexandria S. Coles Dunja Knezevic Tony P. George Tony P. George Christoph U. Correll Christoph U. Correll Christoph U. Correll John M. Kane John M. Kane David Castle David Castle Long-Acting Injectable Antipsychotic Treatment in Schizophrenia and Co-occurring Substance Use Disorders: A Systematic Review Frontiers in Psychiatry schizophrenia substance use disorder (SUD) long acting injectable (LAI) antipsychotic treatment |
| title | Long-Acting Injectable Antipsychotic Treatment in Schizophrenia and Co-occurring Substance Use Disorders: A Systematic Review |
| title_full | Long-Acting Injectable Antipsychotic Treatment in Schizophrenia and Co-occurring Substance Use Disorders: A Systematic Review |
| title_fullStr | Long-Acting Injectable Antipsychotic Treatment in Schizophrenia and Co-occurring Substance Use Disorders: A Systematic Review |
| title_full_unstemmed | Long-Acting Injectable Antipsychotic Treatment in Schizophrenia and Co-occurring Substance Use Disorders: A Systematic Review |
| title_short | Long-Acting Injectable Antipsychotic Treatment in Schizophrenia and Co-occurring Substance Use Disorders: A Systematic Review |
| title_sort | long acting injectable antipsychotic treatment in schizophrenia and co occurring substance use disorders a systematic review |
| topic | schizophrenia substance use disorder (SUD) long acting injectable (LAI) antipsychotic treatment |
| url | https://www.frontiersin.org/articles/10.3389/fpsyt.2021.808002/full |
| work_keys_str_mv | AT alexandriascoles longactinginjectableantipsychotictreatmentinschizophreniaandcooccurringsubstanceusedisordersasystematicreview AT dunjaknezevic longactinginjectableantipsychotictreatmentinschizophreniaandcooccurringsubstanceusedisordersasystematicreview AT tonypgeorge longactinginjectableantipsychotictreatmentinschizophreniaandcooccurringsubstanceusedisordersasystematicreview AT tonypgeorge longactinginjectableantipsychotictreatmentinschizophreniaandcooccurringsubstanceusedisordersasystematicreview AT christophucorrell longactinginjectableantipsychotictreatmentinschizophreniaandcooccurringsubstanceusedisordersasystematicreview AT christophucorrell longactinginjectableantipsychotictreatmentinschizophreniaandcooccurringsubstanceusedisordersasystematicreview AT christophucorrell longactinginjectableantipsychotictreatmentinschizophreniaandcooccurringsubstanceusedisordersasystematicreview AT johnmkane longactinginjectableantipsychotictreatmentinschizophreniaandcooccurringsubstanceusedisordersasystematicreview AT johnmkane longactinginjectableantipsychotictreatmentinschizophreniaandcooccurringsubstanceusedisordersasystematicreview AT davidcastle longactinginjectableantipsychotictreatmentinschizophreniaandcooccurringsubstanceusedisordersasystematicreview AT davidcastle longactinginjectableantipsychotictreatmentinschizophreniaandcooccurringsubstanceusedisordersasystematicreview |